Los Angeles Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Los Angeles Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.17M	Buy	491,841 +363,965	+285%	+$1.26M	﹤0.01%	637
2025 Q4	$541K	Sell	127,876 -20,576	-14%	-$99.7K	﹤0.01%	858
2025 Q3	$626K	Sell	148,452 -131,470	-47%	-$611K	﹤0.01%	848
2025 Q2	$1.02M	Sell	279,922 -56,048	-17%	-$209K	﹤0.01%	632
2025 Q1	$1.45M	Buy	335,970 +11,959	+4%	+$48.3K	0.01%	464
2024 Q4	$1.04M	Sell	324,011 -6,280	-2%	-$21.1K	﹤0.01%	607
2024 Q3	$945K	Sell	330,291 -38,300	-10%	-$107K	﹤0.01%	666
2024 Q2	$1.03M	Sell	368,591 -131,976	-26%	-$354K	﹤0.01%	643
2024 Q1	$1.42M	Buy	500,567 +157,575	+46%	+$536K	﹤0.01%	580
2023 Q4	$1.4M	Sell	342,992 -53,030	-13%	-$149K	0.01%	561
2023 Q3	$1.26M	Sell	396,022 -145,952	-27%	-$464K	0.01%	564
2023 Q2	$1.8M	Buy	541,974 +38,651	+8%	+$114K	0.01%	518
2023 Q1	$1.07M	Buy	503,323 +117,075	+30%	+$289K	﹤0.01%	647
2022 Q4	$1.04M	Sell	386,248 -52,655	-12%	-$154K	0.01%	696
2022 Q3	$1.42M	Sell	438,903 -7,206	-2%	-$32.6K	0.01%	591
2022 Q2	$2.18M	Buy	446,109 +314,414	+239%	+$1.94M	0.01%	516
2022 Q1	$1M	Buy	131,695 +64,124	+95%	+$496K	﹤0.01%	759
2021 Q4	$624K	Buy	+67,571	New	+$718K	﹤0.01%	901

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Los Angeles Capital Management's ORGO Position: Q1 2026 in Review

Los Angeles Capital Management increased its Organogenesis Holdings (ORGO) stake by 285% in Q1 2026, buying an estimated $1.26M and bringing the position to 491,841 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #637.

Los Angeles Capital Management first reported a position in ORGO in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.18M in Q2 2022. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Los Angeles Capital Management held 491,841 shares of Organogenesis Holdings worth $1.17M as of Q1 2026.
Los Angeles Capital Management bought 363,965 Organogenesis Holdings shares in Q1 2026, an estimated $1.26M.
Organogenesis Holdings made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #637 holding.
Los Angeles Capital Management first reported a position in Organogenesis Holdings in Q4 2021 and has held it in 18 quarters since.
Los Angeles Capital Management's Organogenesis Holdings position peaked at $2.18M in Q2 2022.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.